SOURCE: Aldagen

January 23, 2008 09:00 ET

Aldagen to Present at Leerink Swann and Wachovia Investor Conferences

DURHAM, NC--(Marketwire - January 23, 2008) - Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen, will be presenting at two upcoming investor conferences.

On January 24, 2008, Mr. Amick will present at the Leerink Swann Novel Biologic Therapeutics Roundtable Conference, and on January 31, 2008, Mr. Amick will present at the 2008 Wachovia Healthcare Conference.

The following are specific details of Aldagen's presentation at these conferences:

Leerink Swann Novel Biologic Therapeutics Roundtable Conference

Date: Thursday, January 24, 2008
Time: 11:00 AM
Location: Le Parker Meridien, New York, NY


2008 Wachovia Healthcare Conference

Date: Thursday, January 31, 2008
Time: 2:00 PM
Location: The Langham Hotel, Boston, MA
Room: Palmer Room

About Aldagen, Inc.

ALDAGEN is a biotechnology company advancing a pipeline of clinical-stage regenerative therapies. The Company has three product candidates in clinical development for chronic heart failure, critical limb ischemia and pediatric metabolic disorders and malignancies. ALDAGEN's therapeutics are produced by a proprietary technology platform that selects potent, adult stem and progenitor cells for therapeutic use. The platform yields a broad range of therapeutic cells that can be used rapidly, without culture or expansion. To learn more about ALDAGEN, please visit www.aldagen.com.

Contact Information